Portfolio (Quarterly)
Guide ↗
ADAR1 Capital Management, LLC
· CIK 0001940272| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | CTMX | CYTOMX THERAPEUTICS INC. | Healthcare | 3,410,190.0 | $16.0M | 0.94% | NEW | — | $4.70 | -22.6% |
| 22 | PRTA | PROTHENA CORP PLC | Healthcare | 1,581,443.0 | $15.4M | 0.91% | NEW | — | $9.72 | -6.7% |
| 23 | SNY | SANOFI SA | Healthcare | 316,939.0 | $15.3M | 0.90% | NEW | — | $48.18 | -9.6% |
| 24 | PCVX | VAXCYTE INC | Healthcare | 259,137.0 | $15.1M | 0.89% | NEW | — | $58.11 | -16.1% |
| 25 | — | MONOPAR THERAPEUTICS INC | — | 264,278.0 | $14.5M | 0.85% | NEW | — | $54.79 | — |
| 26 | ABUS | ARBUTUS BIOPHARMA CORP | Healthcare | 3,133,175.0 | $14.1M | 0.83% | NEW | — | $4.50 | -2.9% |
| 27 | AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | 1,000,604.0 | $13.9M | 0.82% | NEW | — | $13.90 | -2.1% |
| 28 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 427,816.0 | $13.6M | 0.80% | NEW | — | $31.72 | -4.9% |
| 29 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 2,979,429.0 | $13.3M | 0.78% | NEW | — | $4.47 | +16.1% |
| 30 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 228,899.0 | $13.3M | 0.78% | NEW | — | $58.15 | -7.1% |
| 31 | — | SUTRO BIOPHARMA INC | — | 524,441.0 | $13.1M | 0.77% | NEW | — | $24.91 | — |
| 32 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 133,893.0 | $13.0M | 0.77% | NEW | — | $97.25 | +51.5% |
| 33 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 329,540.0 | $12.9M | 0.76% | NEW | — | $39.20 | +2.5% |
| 34 | CGON | CG ONCOLOGY INC | Healthcare | 185,699.0 | $12.6M | 0.74% | NEW | — | $67.68 | -4.3% |
| 35 | BIL | SPDR SERIES TRUST | — | 135,585.0 | $12.4M | 0.73% | NEW | — | $91.64 | -0.1% |
| 36 | ESTA | ESTABLISHMENT LABS HLDGS INC | Healthcare | 213,473.0 | $12.1M | 0.71% | NEW | — | $56.78 | +15.4% |
| 37 | REPL | REPLIMUNE GROUP INC | Healthcare | 1,582,987.0 | $12.1M | 0.71% | NEW | — | $7.65 | -38.6% |
| 38 | IVA | INVENTIVA SA | Healthcare | 2,174,398.0 | $12.1M | 0.71% | NEW | — | $5.55 | -11.5% |
| 39 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 160,338.0 | $12.0M | 0.71% | NEW | — | $75.09 | -1.7% |
| 40 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 161,252.0 | $11.6M | 0.68% | NEW | — | $71.95 | -6.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
94.6%
Financial Services
4.9%
Real Estate
0.1%
Consumer Cyclical
0.1%
Technology
0.1%
Communication Services
0.1%
Industrials
0.1%
Basic Materials
0.1%